Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Latest News about EDIT Recent news which mentions EDIT < Previous 1 2 3 4 5 6 7 8 9 Next > 3 Gene-Editing Stocks That Could Be Multibaggers in the Making: July Edition July 17, 2024 Tickers CRSP EDIT NTLA Tags EDIT Stocks to Buy Market News From InvestorPlace 3 Profitable CRISPR Stocks Earning Analysts’ Praise July 09, 2024 Tickers CRSP EDIT NTLA Tags CRSP NTLA Market News From InvestorPlace The 3 Best Gene Editing Stocks to Buy in July 2024 July 08, 2024 Tickers CRSP EDIT GNOM ILMN Tags MRNA NASDAQ:NTLA,NASDAQ:EDIT,NASDAQ:GNOM,NASDAQ:NTRA,NASDAQ:MRNA,NASDAQ:CRSP,NASDAQ:MYGN,NASDAQ:ILMN NTRA From InvestorPlace Rags to Riches: 3 Gene Editing Stocks That Could Make Early Investors Rich June 26, 2024 Tickers CRSP EDIT NLTA Tags NASDAQ:CRSP,NASDAQ:EDIT,NASDAQ:NLTA EDIT Stocks to Buy From InvestorPlace 3 Gene Editing Stocks That Could Make Your Grandchildren Rich June 25, 2024 Tickers CRSP EDIT NTLA Tags Stocks to Buy EDIT NTLA From InvestorPlace Unveiling 5 Analyst Insights On Editas Medicine June 18, 2024 Tickers EDIT Tags BZI/AAR EDIT Analyst Ratings From Benzinga The Analyst Verdict: Editas Medicine In The Eyes Of 4 Experts May 30, 2024 Tickers EDIT Tags Analyst Ratings BZI/AAR EDIT From Benzinga Overlooked and Undervalued: 3 Stocks With Jaw-Dropping Upside Potential May 30, 2024 Tickers CNXC EDIT Z Tags Z Uncategorized Market News From InvestorPlace 1 Wall Street Analyst Thinks Editas Medicine Stock Is Going to $15. Is It a Buy Around $5? May 09, 2024 Tickers C EDIT Tags EDIT C Recent Press Releases From Motley Fool EDIT Stock Earnings: Editas Medicine Misses EPS, Misses Revenue for Q1 2024 May 08, 2024 Tickers EDIT Tags EDIT Earnings Reports NASDAQ:EDIT From InvestorPlace 1 Wall Street Analyst Raises Editas Medicine's Price Target by 45%. Here's Why She's Right. March 07, 2024 Tickers EDIT Tags Recent Press Releases Market News EDIT From Motley Fool 1 Beaten-Down Stock With 55% Upside, According to Wall Street March 04, 2024 Tickers EDIT Tags Recent Press Releases Market News EDIT From Motley Fool Why Editas Medicine Stock Soared as Much as 42% Higher This Week March 02, 2024 Tickers C EDIT VRTX Tags EDIT C VRTX From Motley Fool The Latest Analyst Ratings For Editas Medicine February 29, 2024 Tickers EDIT Tags EDIT BZI/AAR Analyst Ratings From Benzinga Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session February 28, 2024 Tickers AAP ACMR ADIL ADT Tags GTLS PGNY BYND From Benzinga Advance Auto Parts Reports Q4 Results, Joins B&G Foods, Vipshop, ADT And Other Big Stocks Moving Higher On Wednesday February 28, 2024 Tickers AAP ACMR ADT ADY Tags Market News Markets ACMR From Benzinga Earnings Outlook For Editas Medicine February 27, 2024 Tickers EDIT Tags Benzinga Earnings Market News From Benzinga 2 Under-the-Radar Stocks With Incredible Upside Potential January 28, 2024 Tickers EDIT RXRX Tags EDIT RXRX Recent Press Releases From Motley Fool Could Editas Medicine Become the Next CRISPR Therapeutics? January 21, 2024 Tickers CRSP EDIT Tags EDIT CRSP Market News From Motley Fool 7 Mighty Healthcare Stocks Changing the Game of Medicine January 17, 2024 Tickers ASXC EDIT HOLX ILMN Tags MRNA Market News EDIT From InvestorPlace Down 88%, Could Editas Medicine Be a Good Investment Now? January 15, 2024 Tickers CRSP EDIT VRTX Tags Recent Press Releases Market News VRTX From Motley Fool 3 Stocks to Buy in the Booming Field of Gene Editing January 11, 2024 Tickers BEAM EDIT LLY VERV Tags NASDAQ:EDIT,NASDAQ:VRTX,NASDAQ:BEAM,NASDAQ:VERV,NYSE:LLY Market News BEAM From InvestorPlace Better Gene-Editing Stock: Editas Medicine vs. Intellia Therapeutics January 08, 2024 Tickers EDIT NTLA Tags NTLA Recent Press Releases Market News From Motley Fool Editas Just Caught a Break Thanks to Vertex Pharmaceuticals December 23, 2023 Tickers EDIT VRTX Tags Recent Press Releases Market News VRTX From Motley Fool Vertex’s stock heads for all-time high as non-opioid painkiller shows promise December 13, 2023 Tickers EDIT SPX VRTX VTRS Tags VTRS EDIT VRTX From MarketWatch The Latest Analyst Ratings for Editas Medicine December 12, 2023 Tickers EDIT Tags Analyst Ratings BZI/AAR EDIT From Benzinga Crispr Therapeutics, Vertex get FDA approval for breakthrough gene-editing treatment December 08, 2023 Tickers BLUE CRSP EDIT VRTX Tags CRSP VRTX BLUE From MarketWatch 1 Promising Stock Down 66% That Could Skyrocket in 2024 December 05, 2023 Tickers EDIT Tags Market News Recent Press Releases EDIT From Motley Fool You Don't Have to Pick a Winner in Gene-Editing. Do This Instead. December 04, 2023 Tickers ARKG BEAM CRBU CRSP Tags PRME HOOD REGN From Motley Fool If You Can Only Buy One Biotech Stock in December, It Better Be One of These 3 Names November 29, 2023 Tickers BLUE EDIT GPCR Tags Stocks to Buy NASDAQ:EDIT,NASDAQ:BLUE,NASDAQ:GPCR EDIT From InvestorPlace < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.